Lipopolysaccharide is a direct agonist for platelet RNA splicing

Journal of Immunology

Volumn 181, Issue 5, 2008, Pages 3495-3502

  Shashkin, Pavel N ^a   Brown, G Thomas ^a   Ghosh, Arundhati ^a   Marathe, Gopal K ^a   McIntyre, Thomas M ^a  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CD14 ANTIGEN; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; PADGEM PROTEIN; THROMBIN;

ARTICLE; BACTERIUM; CELL GRANULE; FLOW CYTOMETRY; GRANULE CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INNATE IMMUNITY; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; CELL ADHESION; CELL CULTURE; DRUG EFFECT; GENETICS; METABOLISM;

BLOOD PLATELETS; CELL ADHESION; CELLS, CULTURED; CYCLOOXYGENASE 2; HUMANS; INTERLEUKIN-1BETA; LEUKOCYTES; LIPOPOLYSACCHARIDES; PLATELET ACTIVATION; PLATELET AGGREGATION; RNA SPLICING; RNA, MESSENGER;

EID: 51549106751     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.5.3495     Document Type: Article

References (43)

1. Palsson-McDermott, E. M., and L. A. O'Neill. 2004. Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 113: 153-162. (Pubitemid 39312442)
2. Andonegui, G., S. M. Kerfoot, K. McNagny, K. V. Ebbert, K. D. Patel, and P. Kubes. 2005. Platelets express functional Toll-like receptor-4. Blood 106: 2417-2423. (Pubitemid 41510815)
3. Cognasse, F., H. Hamzeh, P. Chavarin, S. Acquart, C. Genin, and O. Garraud. 2005. Evidence of Toll-like receptor molecules on human platelets. Immunol. Cell Biol. 83: 196-198. (Pubitemid 40469328)
4. Aslam, R., E. R. Speck, M. Kim, A. R. Crow, K. W. Bang, F. P. Nestel, H. Ni, A. H. Lazarus, J. Freedman, and J. W. Semple. 2006. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-α production in vivo. Blood 107: 637-641. (Pubitemid 43076388)
5. Stahl, A. L., M. Svensson, M. Morgelin, C. Svanborg, P. I. Tarr, J. C. Mooney, S. L. Watkins, R. Johnson, and D. Karpman. 2006. Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood 108: 167-176.
6. Lodrup Carlsen, K. C., and B. Granum. 2007. Soluble CD14: role in atopic disease and recurrent infections, including otitis media. Curr. Allergy Asthma Rep. 7: 436-443.
7. Rumbaut, R. E., R. V. Bellera, J. K. Randhawa, C. N. Shrimpton, S. K. Dasgupta, J. F. Dong, and A. R. Burns. 2006. Endotoxin enhances microvascular thrombosis in mouse cremaster venules via a TLR4-dependent, neutrophil- independent mechanism. Am. J. Physiol. 290: H1671-H1679.
8. Clark, S. R., A. C. Ma, S. A. Tavener, B. McDonald, Z. Goodarzi, M. M. Kelly, K. D. Patel, S. Chakrabarti, E. McAvoy, G. D. Sinclair, et al. 2007. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat. Med. 13: 463-469.
9. Montrucchio, G., O. Bosco, L. Del Sorbo, P. Fascio Pecetto, E. Lupia, A. Goffi, P. Omede, G. Emanuelli, and G. Camussi. 2003. Mechanisms of the priming effect of low doses of lipopolysaccharides on leukocyte-dependent platelet aggregation in whole blood. Thromb. Haemostasis 90: 872-881.
10. Ward, J. R., L. Bingle, H. M. Judge, S. B. Brown, R. F. Storey, M. K. Whyte, S. K. Dower, D. J. Buttle, and I. Sabroe. 2005. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. Thromb. Haemostasis 94: 831-838.
11. Weyrich, A. S., D. A. Dixon, R. Pabla, M. R. Elstad, T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. 1998. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc. Natl. Acad. Sci. USA 95: 5556-5561.
12. Bahou, W. F., and D. V. Gnatenko. 2004. Platelet transcriptome: the application of microarray analysis to platelets. Semin. Thromb. Hemostasis 30: 473-484. (Pubitemid 39180722)
13. Macaulay, I. C., P. Carr, A. Gusnanto, W. H. Ouwehand, D. Fitzgerald, and N. A. Watkins. 2005. Platelet genomics and proteomics in human health and disease. J. Clin. Invest. 115: 3370-3377. (Pubitemid 43121821)
14. Dittrich, M., I. Birschmann, J. Pfrang, S. Herterich, A. Smolenski, U. Walter, and T. Dandekar. 2006. Analysis of SAGE data in human platelets: features of the transcriptome in an anucleate cell. Thromb. Haemostasis 95: 643-651.
15. Pabla, R., A. S. Weyrich, D. A. Dixon, P. F. Bray, T. M. McIntyre, S. M. Prescott, and G. A. Zimmerman. 1999. Integrin-dependent control of translation: engagement of integrin αIIbβ3 regulates synthesis of proteins in activated human platelets. J. Cell Biol. 144: 175-184. (Pubitemid 29047020)
16. Lindemann, S., N. D. Tolley, D. A. Dixon, T. M. McIntyre, S. M. Prescott, G. A. Zimmerman, and A. S. Weyrich. 2001. Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis. J. Cell Biol. 154: 485-490. (Pubitemid 34286155)
17. Lindemann, S., N. D. Tolley, J. R. Eyre, L. W. Kraiss, T. M. Mahoney, and A. S. Weyrich. 2001. Integrins regulate the intracellular distribution of eukaryotic initiation factor 4e in platelets: a checkpoint for translational control. J. Biol. Chem. 276: 33947-33951. (Pubitemid 37384620)
18. Denis, M. M., N. D. Tolley, M. Bunting, H. Schwertz, H. Jiang, S. Lindemann, C. C. Yost, F. J. Rubner, K. H. Albertine, K. J. Swoboda, et al. 2005. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell 122: 379-391.
19. Schwertz, H., N. D. Tolley, J. M. Foulks, M. M. Denis, B. W. Risenmay, M. Buerke, R. E. Tilley, M. T. Rondina, E. M. Harris, L. W. Kraiss, et al. 2006. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J. Exp. Med. 203: 2433-2440. (Pubitemid 44664613)
20. Panes, O., V. Matus, C. G. Saez, T. Quiroga, J. Pereira, and D. Mezzano. 2007. Human platelets synthesize and express functional tissue factor. Blood 109: 5242-5250. (Pubitemid 46890544)
21. Hawrylowicz, C. M., G. L. Howells, and M. Feldmann. 1991. Platelet-derived interleukin 1 induces human endothelial adhesion molecule expression and cytokine production. J. Exp. Med. 174: 785-790.
22. Hawrylowicz, C. M., S. A. Santoro, F. M. Platt, and E. R. Unanue. 1989. Activated platelets express IL-1 activity. J. Immunol. 143: 4015-4018.
23. Loppnow, H., R. Bil, S. Hirt, U. Schonbeck, M. Herzberg, K. Werdan, E. T. Rietschel, E. Brandt, and H. D. Flad. 1998. Platelet-derived interleukin-1 induces cytokine production, but not proliferation of human vascular smooth muscle cells. Blood 91: 134-141. (Pubitemid 28018737)
24. Pillitteri, D., S. Bassus, K. Boller, R. Mahnel, T. Scholz, D. Westrup, W. Wegert, and C. M. Kirchmaier. 2007. Thrombin-induced interleukin 1β synthesis in platelet suspensions: impact of contaminating leukocytes. Platelets 18: 119-127. (Pubitemid 46398996)
25. van der Meer, P. F., J. W. Gratama, C. J. van Delden, R. F. Laport, W. H. Levering, J. G. Schrijver, M. J. Tiekstra, M. Keeney, and J. de Wildt-Eggen. 2001. Comparison of five platforms for enumeration of residual leucocytes in leucoreduced blood components. Br. J. Haematol. 115: 953-962.
26. Semple, J. W., E. R. Speck, D. Cosgrave, A. H. Lazarus, V. S. Blanchette, and J. Freedman. 1999. Extreme leukoreduction of major histocompatibility complex class II positive B cells enhances allogeneic platelet immunity. Blood 93: 713-720.
27. Kinsella, B. T., D. O'Mahony, J. A. Lawson, D. Pratico, and G. A. Fitzgerald. 1994. Cellular activation of thromboxane receptors. Ann. NY Acad. Sci. 714: 270-278.
28. Simmons, D. L., R. M. Botting, and T. Hla. 2004. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol. Rev. 56: 387-437.
29. Patrono, C., and B. Rocca. 2007. Drug insight: aspirin resistance: fact or fashion? Nat. Clin. Pract. Cardiovasc. Med. 4: 42-50. (Pubitemid 44971071)
30. Censarek, P., K. Freidel, M. Udelhoven, S. J. Ku, T. Hohlfeld, J. Meyer-Kirchrath, K. Schror, and A. A. Weber. 2004. Cyclooxygenase COX- 2a, a novel COX-2 mRNA variant, in platelets from patients after coronary artery bypass grafting. Thromb. Haemostasis 92: 925-928. (Pubitemid 39545513)
31. Weber, A. A., B. Przytulski, M. Schumacher, N. Zimmermann, E. Gams, T. Hohlfeld, and K. Schror. 2002. Flow cytometry analysis of platelet cyclooxygenase- 2 expression: induction of platelet cyclooxygenase-2 in patients undergoing coronary artery bypass grafting. Br. J. Haematol. 117: 424-426.
32. Rocca, B., P. Secchiero, G. Ciabattoni, F. O. Ranelletti, L. Catani, L. Guidotti, E. Melloni, N. Maggiano, G. Zauli, and C. Patrono. 2002. Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. Proc. Natl. Acad. Sci. USA 99: 7634-7639. (Pubitemid 34568743)
33. Patrignani, P., M. G. Sciulli, S. Manarini, G. Santini, C. Cerletti, and V. Evangelista. 1999. COX-2 is not involved in thromboxane biosynthesis by activated human platelets. J. Physiol. Pharmacol. 50: 661-667. (Pubitemid 30022144)
34. Reiter, R., U. Resch, and H. Sinzinger. 2001. Do human platelets express COX-2? Prostaglandins Leukotrienes Essent. Fatty Acids 64: 299-305. (Pubitemid 32695301)
35. Weyrich, A. S., S. Lindemann, N. D. Tolley, L. W. Kraiss, D. A. Dixon, T. M. Mahoney, S. P. Prescott, T. M. McIntyre, and G. A. Zimmerman. 2004. Change in protein phenotype without a nucleus: translational control in platelets. Semin. Thromb. Hemostasis 30: 491-498.
36. Weyrich, A. S., M. M. Denis, J. R. Kuhlmann-Eyre, E. D. Spencer, D. A. Dixon, G. K. Marathe, T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott. 2005. Dipyridamole selectively inhibits inflammatory gene expression in plateletmonocyte aggregates. Circulation 111: 633-642. (Pubitemid 40216492)
37. Lien, E., T. K. Means, H. Heine, A. Yoshimura, S. Kusumoto, K. Fukase, M. J. Fenton, M. Oikawa, N. Qureshi, B. Monks, et al. 2000. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105: 497-504. (Pubitemid 30127250)
38. Morr, M., O. Takeuchi, S. Akira, M. M. Simon, and P. F. Muhlradt. 2002. Differential recognition of structural details of bacterial lipopeptides by toll-like receptors. Eur. J. Immunol. 32: 3337-3347. (Pubitemid 36024371)
39. Frey, E. A., D. S. Miller, T. G. Jahr, A. Sundan, V. Bazil, T. Espevik, B. B. Finlay, and S. D. Wright. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176: 1665-1671.
40. Pugin, J., C. C. Schurer-Maly, D. Leturcq, A. Moriarty, R. J. Ulevitch, and P. S. Tobias. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 90: 2744-2748. (Pubitemid 23113493)
41. Semple, J. W., M. Coopamh, and J. Freedman. 2004. Murine platelets express toll like receptor 2: A potential regulator of innate and adaptive immunity. Platelets 15: 267.
42. Shiraki, R., N. Inoue, S. Kawasaki, A. Takei, M. Kadotani, Y. Ohnishi, J. Ejiri, S. Kobayashi, K. Hirata, S. Kawashima, and M. Yokoyama. 2004. Expression of Toll-like receptors on human platelets. Thromb. Res. 113: 379-385. (Pubitemid 38844368)
43. Weyrich, A. S., M. M. Denis, H. Schwertz, N. D. Tolley, J. Foulks, E. Spencer, L. W. Kraiss, K. H. Albertine, T. M. McIntyre, and G. A. Zimmerman. 2006. mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets. Blood 109: 1975-1983.